Jimini Health
Pre Seed Round in 2024
Jimini Health improves mental health care globally through a novel model combining teletherapy sessions with personalized AI support. Founded in 2023 by experts in AI, biotech, and psychology, Jimini ensures clinically beneficial patient journeys led by licensed clinicians, augmented by AI for enhanced care.
Mural Health
Seed Round in 2023
Mural Health develops technology for clinical trials to simplify participation and improve enrollment and retention in studies. Founded in 2022 and based in Berwyn, Pennsylvania, the company creates clinical research tools designed to ease global participation. Its initial feature set includes transportation coordination, multi-way messaging, and participant feedback, enabling healthcare professionals to manage the trial experience for patients and caregivers and reduce barriers to enrolling in and remaining in trials.
Sollis Health
Series A in 2023
Sollis Health offers concierge urgent and emergency care with round-the-clock access to medical facilities and ER physicians who manage care from check-in through follow-up. The service suite includes advanced diagnostic imaging, VIP support from leading hospitals, and fast access to a hand-selected network of specialists, along with executive health programs and proactive preventive services to improve medical experience during acute illnesses or emergencies.
Nanite is a biotechnology company focused on non-viral gene delivery through the development of programmable polymer nanoparticles. Utilizing an artificial intelligence-driven platform, Nanite integrates advanced high-throughput experimental and computational techniques to create tailored delivery vehicles capable of transporting a diverse array of genetic materials with specific targeting capabilities. This innovative approach aims to assist scientists in functional chemistry by providing therapeutically relevant solutions for gene delivery, enhancing the potential for various medical applications and indications.
Elaborate
Seed Round in 2023
Elaborate is a clinical intelligence platform focused on reducing physician burnout by automating administrative tasks associated with patient care. The company leverages patients' health data to streamline workflows in areas such as results management, referral processing, and visit preparation, thereby alleviating the administrative burden on clinicians. Its platform integrates with electronic medical records and employs a proprietary clinical insights engine to analyze patient data, enabling healthcare providers to generate personalized reports that clearly summarize lab results for patients. Trusted by health systems, academic medical centers, and multi-specialty groups, Elaborate enhances compliance and improves communication between doctors and patients.
Cofertility
Seed Round in 2022
Cofertility is a human-centered fertility ecosystem that offers egg donation and egg-freezing services for fertility care and third-party reproduction. The platform connects women who wish to store eggs with families unable to conceive, providing a scalable model for egg donation and enabling free egg freezing when donors donate half of their eggs to another family. By matching candidates with donors, coordinating freezing and donation, Cofertility supports individuals and families throughout the fertility journey and aims to improve access to family-building options.
CertifyOS is a data intelligence company focused on enhancing the accessibility of provider data within the U.S. healthcare system. Its platform automates the entire provider network management lifecycle through an API-first, user interface agnostic approach. By integrating with numerous primary sources, CertifyOS facilitates near real-time verification and credentialing processes for provider enrollment. This capability positions the company as a comprehensive solution for insurance companies and virtual care providers, allowing them to efficiently manage and scale their provider networks while simplifying tasks such as licensing, monitoring, and sourcing providers.
Mable (Neurolytic Healthcare)
Seed Round in 2022
Neurolytic Healthcare Ltd. is a medical technology company based in Oxford, United Kingdom, specializing in the design, development, and manufacture of digital and genomic-based diagnostic tools and medical devices for migraine and related neurological disorders. Founded in 2016, the company focuses on personalized medicine by integrating genetic and biomarker data to enhance diagnosis and assist clinicians in determining optimal treatment strategies. Its product offerings include a diagnostic support tool, a pharmacogenetic test, and a mobile application designed to predict migraine events. By leveraging artificial intelligence, Neurolytic Healthcare aims to provide genomics-driven diagnostics and personalized treatment recommendations, helping patients find effective treatments while minimizing side effects and reducing the trial-and-error approach often associated with neurological care.
Canaery
Seed Round in 2022
Canaery is developing a neural interface that analyzes an object's scent fingerprint to identify dangerous compounds at ports and inspection points, potentially replacing or supplementing x-ray and camera methods. The company aims to digitize the sense of scent through a neurotech device that interprets scents entering an olfactory system and prioritizes those relevant to customers, enabling the identification of hazardous compounds and the underlying object or its state. By translating olfactory information into actionable signals, Canaery seeks to enhance security and inspection efficiency in high-risk environments.
Vibe Bio
Venture Round in 2022
Vibe Bio is a community-driven organization focused on addressing rare diseases by identifying, funding, and developing innovative treatments. By leveraging a platform that connects patients, scientists, and partners, Vibe Bio supports the development of promising therapies for overlooked conditions. The company utilizes cryptocurrency token sales as a unique funding mechanism, enabling sustainable development of treatments. This approach not only empowers patient communities but also grants them significant ownership in the process of discovering new cures. Through collaboration and shared resources, Vibe Bio aims to transform the landscape of rare disease treatment.
Culina Health
Seed Round in 2022
Culina Health provides personalized virtual nutrition counseling through registered dietitians. It focuses on improving health outcomes for patients with chronic conditions, offering culturally competent support tailored to individual needs.
Handspring Health
Seed Round in 2022
Handspring Health redesigns family mental healthcare delivery. It integrates in-person, digital, and device-based care through technology, health plan partnerships, and trained clinicians to make quality mental healthcare more accessible.
Certify
Seed Round in 2022
CertifyOS is a data intelligence company focused on enhancing the accessibility of provider data within the U.S. healthcare system. Its platform automates the entire provider network management lifecycle through an API-first, user interface agnostic approach. By integrating with numerous primary sources, CertifyOS facilitates near real-time verification and credentialing processes for provider enrollment. This capability positions the company as a comprehensive solution for insurance companies and virtual care providers, allowing them to efficiently manage and scale their provider networks while simplifying tasks such as licensing, monitoring, and sourcing providers.
Sollis Health
Series A in 2022
Sollis Health offers concierge urgent and emergency care with round-the-clock access to medical facilities and ER physicians who manage care from check-in through follow-up. The service suite includes advanced diagnostic imaging, VIP support from leading hospitals, and fast access to a hand-selected network of specialists, along with executive health programs and proactive preventive services to improve medical experience during acute illnesses or emergencies.
NOVOS
Pre Seed Round in 2021
NOVOS is a brand focused on longevity supplements, aiming to enhance users' lives through science-backed products designed to slow down aging processes. Their offerings include healthcare drinks enriched with anti-aging ingredients like nicotinamide riboside, magnesium, fisetin, and pterostilbene, along with antioxidants and other functional components that facilitate DNA repair and reduce damage, thereby potentially extending lifespan and improving overall health.
Connie Health
Series A in 2021
Connie Health assists older Americans in making informed decisions about their healthcare by providing medical advisory services through a technology platform paired with local Medicare experts. They help individuals optimize prescription costs, find healthcare providers, and navigate insurance plan benefits.
QSimulate
Seed Round in 2021
QSimulate is a Boston-based company that specializes in developing cloud-based quantitative simulation tools focused on quantum molecular simulations. By leveraging the principles of quantum mechanics, QSimulate aims to address significant industrial-scale challenges primarily within the chemical and pharmaceutical sectors. Its innovative platform automates various workflows, allowing computational scientists to shift their focus from repetitive tasks to more strategic activities, ultimately enhancing productivity. This approach enables clients to accelerate their research and development processes, positioning QSimulate as a key player in advancing scientific inquiry and innovation in these industries.
Connie Health
Pre Seed Round in 2020
Connie Health assists older Americans in making informed decisions about their healthcare by providing medical advisory services through a technology platform paired with local Medicare experts. They help individuals optimize prescription costs, find healthcare providers, and navigate insurance plan benefits.
HumanFirst
Seed Round in 2019
HumanFirst is a company focused on enhancing patient-centered clinical trials through its advanced precision measures platform, which is recognized as the world's largest AI-powered software-as-a-service solution for improving health outcomes. The platform offers insights and validated evidence data to support biopharmaceutical companies in their drug development processes, enabling them to incorporate digital health technologies, digital biomarkers, and electronic clinical outcome assessments. By providing industry educational tools and facilitating collaboration with research partners, HumanFirst helps biopharma organizations increase research efficiency and accelerate the deployment of innovative treatments. The platform has been utilized by a significant majority of the largest pharmaceutical companies globally, underscoring its role in transforming clinical research and driving the evolution of drug development.
Parsley Health
Series B in 2019
Parsley Health is a health service that integrates technology, nutrition, wellness and prevention into primary care. The company provides subscription-based, personalized healthcare that emphasizes diagnosing and addressing root causes of illness through a holistic approach. Its model combines medical consultations with health coaching, laboratory testing, digital access to records, and referrals to specialists, enabling proactive management of chronic conditions. Services include functional medicine assessments, personalized nutrition plans, stress management and lifestyle support, and access to nutraceuticals and supplements as part of care. Parsley Health operates clinics in major cities and delivers remote care through online tools and telemedicine. Founded in 2016 by Dr. Robin Berzin, the company focuses on data-driven care that supports long-term health rather than episodic treatment.
MEDIVIS
Seed Round in 2019
Medivis is a developer of advanced medical imaging technology that utilizes augmented reality and artificial intelligence to enhance surgical operations. The company's innovative platform enables physicians to overlay holographic images directly onto patients during procedures, facilitating precise decision-making in the operating room. By integrating these technologies, Medivis aims to improve surgical outcomes and streamline the workflow for healthcare professionals, ultimately advancing the field of surgical navigation.
Paradromics
Seed Round in 2018
Paradromics, Inc. is a company focused on developing advanced brain-machine interfaces aimed at transmitting data between the brain and external devices. Founded in 2015 and based in Austin, Texas, Paradromics manufactures implantable systems that facilitate neural data decoding, converting intricate neural recordings into data streams suitable for various neural prostheses. The company's technology is designed to enhance data transmission rates, providing high-volume, bidirectional data streaming capabilities. This innovation aims to assist individuals with neurodegenerative diseases and other neurological conditions by compensating for the loss of biological connectivity. In addition to its core products, Paradromics also develops applications to support its technology solutions.
BehaVR, LLC is a healthcare technology company founded in 2016 and based in Elizabethtown, Kentucky. The company specializes in developing digital therapeutics that leverage virtual reality to address behavioral health challenges, particularly in the context of chronic diseases. BehaVR's platform aims to enhance skills such as stress resilience, emotional regulation, and self-efficacy, enabling individuals to better manage their conditions, adhere to treatment plans, and ultimately improve their overall health outcomes. Through its innovative approach, BehaVR seeks to bridge the gap between behavioral health and chronic disease management.
Cake LLC is a Boston-based company that offers guidance, planning, and consulting services related to end-of-life preferences through its application. This platform allows users to create a secure online document detailing their instructions for various aspects of mortality, including healthcare, funerals, financial, and legal matters. Cake serves as a comprehensive resource, featuring over 1,400 articles and interactive planning tools designed to assist individuals in navigating the complexities of end-of-life decisions. With a monthly reach of over 1.5 million unique visitors, Cake collaborates with various organizations in the healthcare and financial sectors, providing essential support for users looking to curate their digital legacy and make meaningful choices regarding their mortality.
Darmiyan
Seed Round in 2017
Darmiyan develops a SaaS platform, BrainSee, for early detection and monitoring of neurodegenerative diseases like Alzheimer's. Using standard MRI scans and cognitive tests, BrainSee generates detailed brain maps and scores indicating neurodegeneration, enabling timely diagnosis and intervention.
Tia, Inc. is a health advisory platform focused on providing personalized and data-driven healthcare solutions for women. Founded in 2015 and headquartered in New York, with an additional location in San Francisco, Tia offers a mobile application that features a range of services including birth control recommendations, sexual health advice, symptom tracking, and doctor locators. The platform empowers women to make informed decisions about their health by facilitating access to both in-office appointments and virtual care. Recognizing that traditional healthcare systems often overlook women's needs, Tia aims to create a distinctly female-centered model of care that addresses the unique healthcare challenges women face.
Parsley Health
Seed Round in 2017
Parsley Health is a health service that integrates technology, nutrition, wellness and prevention into primary care. The company provides subscription-based, personalized healthcare that emphasizes diagnosing and addressing root causes of illness through a holistic approach. Its model combines medical consultations with health coaching, laboratory testing, digital access to records, and referrals to specialists, enabling proactive management of chronic conditions. Services include functional medicine assessments, personalized nutrition plans, stress management and lifestyle support, and access to nutraceuticals and supplements as part of care. Parsley Health operates clinics in major cities and delivers remote care through online tools and telemedicine. Founded in 2016 by Dr. Robin Berzin, the company focuses on data-driven care that supports long-term health rather than episodic treatment.